The size of the global hernia mesh devices market is expected to be worth USD 3.85 billion in 2021 and is projected to be growing at a CAGR of 3.1%, to touch USD 4.48 billion by 2026.
Hernia treatment includes terminating the weak spot present in the muscle through which the intestinal content is distended. Presently, two treatment options are existing – hernia repair surgeries using sutures and hernia repair surgeries using mesh. The mending of hernia through surgery using mesh does not stress tissues or muscles; the mesh bridges the gap in the muscle/hernia orifice with few stitches or staples. The use of mesh also helps alleviate pain and reduces the chances of recurrence. Many types of mesh products are available in the market, but surgeons typically use a sterile, woven material made from a synthetic plastic-like material, such as polypropylene. The mesh can be in the form of a patch that goes under or over the weakness, or it can be in the form of a plug that goes inside the hole. Mesh is very sturdy and strong, yet extremely thin.
DRIVING FACTORS:
Y-O-Y growth in hernia cases, growing obesity cases, and increasing advanced surgical processes are expected to drive the hernia mesh devices market growth.
The rising adoption of mesh in hernia repair surgeries, growing aged population, and new product launches propel the growth of the global hernia mesh devices market growth. Growing demand for progressive meshes and a high repetitive hernia rate is expected to strengthen the market demand. According to HealthGrove, the mortality rate of hernia per 100,000 people is 0.5, and every year, healthy life lost is 14.7.
The advanced adoption of robotic surgeries coupled with minimally invasive surgeries, laparoscopic techniques for hernia repair, and different types of advantages provided by mesh devices such as avoiding recurring, easy access, and non-reactivity with biological tissues is further anticipated to drive the global hernia mesh devices market. Minimally invasive procedures like laparoscopic surgery are more familiar worldwide as they offer better results than surgical procedures. According to the Food and Drug Administration (FDA), has implemented more than a million hernia surgeries every year in the United States, of which 80,000 processes are of an inguinal type.
Additionally, growing spending by the governments to develop the healthcare infrastructure and advancing regulatory scenarios are to invent new revenue opportunities for the key players.
MARKET RESTRAINTS:
However, factors such as inadequate reimbursement policies among the improving countries and product recall obstruct the market growth. High costs associated with the surgeries and insufficient equipment and infrastructural services among the developing countries are further expected to hinder the market demand. Moreover, the scarcity of trained and experienced professionals required during the surgery also hampers the market growth globally.
Additionally, establishing and executing the hernia procedures in ambulatory surgery regularly exhibit challenges to the surgeons and the patient. The difficulties and threats concerned with hernia repair surgery and mesh are significant challenges to the global hernia mesh devices market.
Impact of COVID-19 on the global hernia mesh devices market:
The SARS-CoV-2 reagents caused the new diseases coronavirus (COVID 19) and were declared a pandemic by the WHO on March 11, 2020, and affected millions of people. The widespread crisis, whose first impact led to the shutdown and then reduced regular medical, hospital, and surgical care worldwide. The Herniated registry data confirmed that more than 70% of all elective hernia-based surgeries were either canceled or postponed during the peaks of the COVID 19 crisis. In February 2019, the elective inguinal hernia operations performed were 7043, and by the end of June, it has come down to 5584. When compared with 2019, in February, the elective inguinal hernia operations implemented were 6699, and by the mid of April, it had a shortfall to 1678. Post to April, the hernia operations have increased to 3033 by the end of June. After the lockdown period, there has been an increase in the hernia mesh devices, as the patients have undergone surgeries to have more life expectancy.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By Hernia Type, Product Type, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
This research report on the global hernia mesh devices market has been segmented and sub-segmented based on the hernia type, product type, and region.
Hernia Mesh Devices Market - By Hernia Type:
The inguinal hernia type segment is predicted to dominate the global hernia mesh devices market with the highest share during the forecast period based on the hernia type. It is expected to be driven by the stress-free procedures and more hurdles engaged in traditional operative techniques due to the patient possibility. The inguinal is ten times more familiar in men than in women leading to a considerable repair amount.
The umbilical segment to register healthy growth during the forecast period due to the burgeoning occurrence of hernia in the upcoming years. The increasing adoption of hernia mesh devices for repairing the hernia that occurs at the belly button compels the segment growth.
Femoral hernia occurrence is shallow and is most common in older women due to the pelvis's extended shape.
Hernia Mesh Devices Market - By Product Type:
The synthetic mesh segment is predicted to dominate the hernia mesh devices market based on the product type. The climbing demand for synthetic meshes integrated with advanced technologies in meshes and new products and device launches are expected to drive market growth.
The biologic mesh segment is foreseen with a healthy growth rate during the forecast period. The biologic mesh is a surgical mesh finished from an organic material comprising porcine small intestine submucosa and porcine dermis. These factors accumulate the hernia mesh devices' market growth.
Hernia Mesh Devices Market - By Region:
Geographically, North America leads the global hernia mesh devices market, accounting for the major global market share, with the US accounting for the major share. North America’s lead is warranted by the presence of a high incidence of obese patients and increasing the use of Hernia Mesh by surgeons. Europe comes in second in terms of market share due to rising awareness about blood-related disorders and the swift availability of treatment in terms of plasma fractionation.
However, Asia-Pacific is expected to expand at the highest CAGR during the forecast period, majorly because of a huge population base, increasing adoption of advanced technologies, and the low manufacturing costs of hernia mesh device emerging economies of the region.
KEY MARKET PARTICIPANTS:
Some of the notable companies dominating the global hernia mesh devices market profiled in this report are Medtronic (U.S.), Ethicon, Inc. (U.S.), C.R. Bard, Inc. (U.S.), Atrium (Sweden), W.L. Gore & Associates (Germany), Lifecell Corporation (U.S.), and B. Braun Melsungen AG (Germany).
KEY MARKET HAPPENINGS IN THE RECENT PAST:
In October 2019, Exogenesis won FDA 510(K) clearance for its hernia mesh implant for its soft tissue repair in abdominal wall hernia and deficiencies.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Hernia Type
5.1.1 Introduction
5.1.2 Inguinal
5.1.3 Umbilical
5.1.4 Hiatal
5.1.5 Femoral
5.1.6 Incisional
5.1.7 Others
5.1.5 Y-o-Y Growth Analysis, By Hernia Type
5.1.6 Market Attractiveness Analysis, By Hernia Type
5.1.7 Market Share Analysis, By Hernia Type
5.2 Product Type
5.2.1 Introduction
5.2.2 Synthetic Mesh
5.2.2.1 Mesh Structure
5.2.2.2 Mesh Absorbance
5.2.3 Biological Mesh
5.2.4 Y-o-Y Growth Analysis, By Product Type
5.2.5 Market Attractiveness Analysis, By Product Type
5.2.6 Market Share Analysis, By Product Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Hernia Type
6.1.3.3 By Product Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Hernia Type
6.1.4.3 By Product Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Hernia Type
6.1.5.3 By Product Type
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 StemCells
8.3 Cryo Cell International
8.4 Geron Corporation
8.5 Mesoblast
8.2 Ethicon
8.3 C R Bard
8.4 Atrium
8.5 W L Gore and Associates
8.6 Lifecell Corporation
8.7 B Braun Melsungen
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
